Homeopathic sleep aid neurexan put to the test in insomnia trial
NCT ID NCT06278077
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed Phase 2 trial tested whether Neurexan, a homeopathic tablet, can improve sleep and reduce stress in 81 people with short-term insomnia. Participants took Neurexan or a placebo for 14 days. Sleep efficiency was measured using brain activity and other body signals, while stress was assessed through cold water hand immersion and hormone tests. The study aims to see if Neurexan offers real benefits over a dummy pill.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Neurexan (a homeopathic combination of passionflower, oat, coffee, and zinc valerianate)
What this could lead to
If it works, this could point toward a natural-like option for easing short-term insomnia and stress without strong side effects.
What could go wrong
This is a small Phase 2 trial with only 81 people, and homeopathic remedies often show no difference from placebo. Results may not be conclusive or generalizable.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INSOMNIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jena University Hospital, Department of Psychiatry & Psychotherapy
Jena, Thuringia, 07743, Germany